News

4PCAN project: Dr Marius Geanta champions bold vision for cancer control at The Economist Impact World Cancer Series Europe

4PCAN project: Dr Marius Geanta champions bold vision for cancer control at The Economist Impact World Cancer Series Europe
Dr Geanta’s insights illuminated a path toward a paradigm shift in cancer prevention and early detection.
Projects

 

Dr Marius Geanta, President of INOMED and Coordinator of the 4P-CAN Project, took centre stage during the Economist Impact World Cancer Series Europe, leaving an important mark on the discourse surrounding cancer control strategies. Dr Geanta’s insights illuminated a path toward a paradigm shift in cancer prevention and early detection.

 

 

During session titled ‘Future-proofing cancer control,’ Dr Geanta emphasized that the status quo in cancer control is no longer tenable. He underscored the urgency of moving beyond reactive approaches that rely on identifying symptoms before acting. Despite monumental strides in diagnosis and treatment, the persistent impact of cancer necessitates a sea change.

 

 

NEWS​

Related News

Finland – Kuopio Health Ecosystem is ECHAlliance Ecosystem of the Month – July

15 Jul 2024
This month we are featuring our Finland - Kuopio Health Ecosystem as our Ecosystem of the Month.

EU JAMRAI- 2: Building a One Health World

15 Jul 2024
The mission at EU-JAMRAI 2 is to lead the fight against antimicrobial resistance (AMR) through joint and coordinated action across Europe.

Team MediBoost Wins AI4Health.Cro Innovation Competition

15 Jul 2024
Team MediBoost clinched the top prize at this year’s AI4Health.Cro innovation competition, winning €5,000 for their groundbreaking application designe...

Tackling obesity

8 Jul 2024
Apply for funding to develop effective strategies to tackle overweight and obesity. ‘Tackling obesity’ is open to applications submitted to the Popula...

Cancer research transatlantic development and skills enhancement award 2024

4 Jul 2024
Following the UK-US Cancer Summit, MRC and NIHR, in partnership with NCI, are launching a second competition for the cancer research transatlantic dev...

24/52 Liver Disease (EME Programme)

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *